The serum concentration of Clobetasone can be increased when it is combined with Estradiol. The serum concentration of Diphenhydramine can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Alogliptin can be decreased when used in combination with Cyproterone acetate. The serum concentration of Nicardipine can be decreased when it is combined with Cyproterone acetate. The metabolism of Estradiol can be decreased when combined with Trimethoprim. The therapeutic efficacy of Acetohexamide can be decreased when used in combination with Cyproterone acetate. The serum concentration of Estradiol can be increased when it is combined with Netupitant. The serum concentration of Estradiol can be decreased when it is combined with GM6001. The serum concentration of 19-norandrostenedione can be increased when it is combined with Estradiol. The therapeutic efficacy of Bempedoic acid can be decreased when used in combination with Cyproterone acetate. Estradiol may decrease the anticoagulant activities of Fondaparinux. The serum concentration of Estradiol can be decreased when it is combined with Enalkiren. The serum concentration of Rimexolone can be increased when it is combined with Estradiol. The serum concentration of Ubidecarenone can be increased when it is combined with Cyproterone acetate. The serum concentration of Zolpidem can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Estradiol can be decreased when used in combination with Sarilumab. Lumiracoxib may increase the thrombogenic activities of Estradiol. The therapeutic efficacy of Estradiol can be decreased when used in combination with Alitretinoin. The serum concentration of Estradiol can be decreased when it is combined with Isoflurophate. The therapeutic efficacy of Ursodeoxycholic acid can be decreased when used in combination with Estradiol. The therapeutic efficacy of Deoxyspergualin can be decreased when used in combination with Estradiol. The serum concentration of Brompheniramine can be decreased when it is combined with Cyproterone acetate. The metabolism of Estradiol can be decreased when combined with Idelalisib. The therapeutic efficacy of Miglustat can be decreased when used in combination with Cyproterone acetate. The therapeutic efficacy of Metformin can be decreased when used in combination with Estradiol. The therapeutic efficacy of Balaglitazone can be decreased when used in combination with Estradiol. The therapeutic efficacy of Insulin Glargine can be decreased when used in combination with Estradiol. The serum concentration of Estradiol can be decreased when it is combined with Prucalopride. The serum concentration of Estradiol can be decreased when it is combined with Mitotane. The metabolism of Estradiol can be decreased when combined with Lapatinib. The serum concentration of Pravastatin can be increased when it is combined with Cyproterone acetate. The serum concentration of anecortave acetate can be increased when it is combined with Estradiol. The serum concentration of Estradiol can be decreased when it is combined with Epigallocatechin Gallate. The serum concentration of Lamotrigine can be decreased when it is combined with Estradiol. The serum concentration of Saxagliptin can be decreased when it is combined with Estradiol. The risk or severity of adverse effects can be increased when Estradiol is combined with Ospemifene. The serum concentration of Estradiol can be decreased when it is combined with Spirapril. The serum concentration of Estradiol can be decreased when it is combined with 1,10-Phenanthroline. The metabolism of Estradiol can be increased when combined with Rifampicin. The risk or severity of adverse effects can be increased when Docetaxel is combined with Cyproterone acetate. The therapeutic efficacy of 2,4-thiazolidinedione can be decreased when used in combination with Cyproterone acetate. The serum concentration of Estradiol can be decreased when it is combined with Vildagliptin. The risk or severity of adverse effects can be increased when Cabazitaxel is combined with Cyproterone acetate. The serum concentration of Estradiol can be decreased when it is combined with Thiorphan. The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Cyproterone acetate. Estradiol may decrease the anticoagulant activities of Citric Acid. The serum concentration of Halothane can be decreased when it is combined with Cyproterone acetate. The serum concentration of Grepafloxacin can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Glipizide can be decreased when used in combination with Estradiol. The serum concentration of 16-Bromoepiandrosterone can be increased when it is combined with Estradiol. The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Estradiol. The serum concentration of Estradiol can be decreased when it is combined with Cholestyramine. The serum concentration of Sevoflurane can be decreased when it is combined with Cyproterone acetate. The serum concentration of Triamterene can be decreased when it is combined with Cyproterone acetate. The serum concentration of Estradiol can be increased when it is combined with Peginterferon alfa-2b. The serum concentration of Cerivastatin can be increased when it is combined with Cyproterone acetate. The serum concentration of Estradiol can be decreased when it is combined with Omapatrilat. The serum concentration of Fluocinolone Acetonide can be increased when it is combined with Estradiol. The serum concentration of Zileuton can be decreased when it is combined with Cyproterone acetate. The serum concentration of Estradiol can be decreased when it is combined with S-3304. The serum concentration of Flumethasone can be increased when it is combined with Estradiol. The serum concentration of Cinacalcet can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Allicin can be decreased when used in combination with Cyproterone acetate. The serum concentration of Isoflurane can be decreased when it is combined with Cyproterone acetate. The metabolism of Estradiol can be decreased when combined with Topiroxostat. The therapeutic efficacy of Sulodexide can be decreased when used in combination with Cyproterone acetate. Estradiol may decrease the anticoagulant activities of Ethyl biscoumacetate. The serum concentration of Estradiol can be decreased when it is combined with Cholesterol. The serum concentration of Estradiol can be decreased when it is combined with Ritonavir. The metabolism of Estradiol can be decreased when combined with Mexiletine. The therapeutic efficacy of Gliclazide can be decreased when used in combination with Cyproterone acetate. The serum concentration of Ergotamine can be decreased when it is combined with Cyproterone acetate. The serum concentration of Riluzole can be decreased when it is combined with Cyproterone acetate. The metabolism of Estradiol can be decreased when combined with Sulfisoxazole. Etodolac may increase the thrombogenic activities of Estradiol. The serum concentration of Haloperidol can be decreased when it is combined with Cyproterone acetate. The serum concentration of Leflunomide can be decreased when it is combined with Cyproterone acetate. The serum concentration of Oxaliplatin can be decreased when it is combined with Cyproterone acetate. The serum concentration of Palonosetron can be decreased when it is combined with Cyproterone acetate. The serum concentration of Omeprazole can be decreased when it is combined with Cyproterone acetate. The metabolism of Estradiol can be decreased when combined with Sulfamethoxazole. The serum concentration of Thalidomide can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Phenformin can be decreased when used in combination with Estradiol. The serum concentration of Enasidenib can be decreased when it is combined with Cyproterone acetate. The serum concentration of Aminophenazone can be decreased when it is combined with Cyproterone acetate. The metabolism of Estradiol can be decreased when combined with Rucaparib. The serum concentration of Clozapine can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Empagliflozin can be decreased when used in combination with Estradiol. The metabolism of Estradiol can be decreased when combined with Nelfinavir. The serum concentration of Olanzapine can be decreased when it is combined with Cyproterone acetate. The serum concentration of Terbinafine can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Glibornuride can be decreased when used in combination with Estradiol. The serum concentration of Phenobarbital can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Nateglinide can be decreased when used in combination with Estradiol. The serum concentration of Carmustine can be decreased when it is combined with Cyproterone acetate. The serum concentration of Estradiol can be decreased when it is combined with Quinapril. The serum concentration of Ritonavir can be decreased when it is combined with Cyproterone acetate. The serum concentration of Dyphylline can be increased when it is combined with Estradiol. The serum concentration of Imipramine can be decreased when it is combined with Cyproterone acetate. Etoricoxib may increase the thrombogenic activities of Estradiol. The serum concentration of Felbamate can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Nateglinide can be decreased when used in combination with Cyproterone acetate. The serum concentration of Tizanidine can be decreased when it is combined with Cyproterone acetate. The serum concentration of Estradiol can be decreased when it is combined with Boceprevir. The serum concentration of Nifedipine can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Glimepiride can be decreased when used in combination with Estradiol. The serum concentration of Estradiol can be decreased when it is combined with Ramipril. Estradiol may decrease the anticoagulant activities of Certoparin. Estradiol may decrease the anticoagulant activities of Warfarin. The serum concentration of Estradiol can be increased when it is combined with Palbociclib. The serum concentration of Zolmitriptan can be decreased when it is combined with Cyproterone acetate. The serum concentration of Corticosterone can be increased when it is combined with Estradiol. The serum concentration of Citalopram can be decreased when it is combined with Cyproterone acetate. Estradiol may increase the thrombogenic activities of Anthrax immune globulin human. The metabolism of Estradiol can be decreased when combined with Amiodarone. The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Estradiol. The serum concentration of Estradiol can be decreased when it is combined with Colestipol. The serum concentration of Metoprolol can be increased when it is combined with Cyproterone acetate. The serum concentration of Estradiol can be decreased when it is combined with Gabexate. The serum concentration of Rilpivirine can be decreased when it is combined with Estradiol. The serum concentration of Estradiol can be increased when it is combined with Ivacaftor. Estradiol may increase the thrombogenic activities of Conestat alfa. The therapeutic efficacy of Insulin Pork can be decreased when used in combination with Cyproterone acetate. The serum concentration of Iloperidone can be decreased when it is combined with Cyproterone acetate. The metabolism of Estradiol can be decreased when combined with Lidocaine. The therapeutic efficacy of Liothyronine can be decreased when used in combination with Estradiol. The serum concentration of Paramethadione can be decreased when it is combined with Cyproterone acetate. The serum concentration of Thiabendazole can be decreased when it is combined with Cyproterone acetate. The therapeutic efficacy of Castanospermine can be decreased when used in combination with Cyproterone acetate. The therapeutic efficacy of Pioglitazone can be decreased when used in combination with Cyproterone acetate.